Buffalo Translational Consortium News

Home-Brewed Drugs and the Drug Development Process

Posted on 06/06/17 at 08:53 am

 

Presented by the UB Clinical and Translational Science Institute Drug Development Core

  • Case studies in drug discovery and pre-clinical development
  • Opportunities to become familiar with GLP and pre-clinical drug development programs
  • Regulatory compliance leading to IND application
  • Strategies for translation to Phase I study design

Who: UB CTSI Investigators with drug discovery and drug development research programs

Where: Roswell Park Cancer Institute, Zebro Conference Room

When: Monthly, 4 – 5 p.m., first Tuesday of each month (except July, second Tuesday)

Schedule:

Date

Presenter(s)

Topic

6/6/17

Andrei Gudkov, PhD, DSc

NAMPT Inhibitor OT-82 targeting energy metabolism in hematologic malignancies

7/11/17

Katerina Gurova, MD, PhD

Joseph Skitzki, MD

Curaxins – Novel epigenetic anticancer drug

8/1/17

Ravindra Pandey, PhD

Sandra Gollnick, PhD

New drug development perspectives in PDT

9/5/17

Lyudmila Burdelya, PhD

Vadim Krivokrysenko. PhD

Entolimod as a dual use oncology biodefense drug

10/3/17

Robert Fenstermaker, MD

Anti-GBM vaccine